Clinical Trials: A Phase 1b/2 Study to Evaluate the Safety and Efficacy of AMG 655 or AMG 479 in Combination With Gemcitabine as First-Line Therapy for Metastatic Pancreatic Cancer

Share this article:
Sponsor and Collaborators
Amgen

Contact
Amgen Call Center
866-572-6436

Principal Investigator
MD Amgen

ClinicalTrials.gov Identifier
NCT00630552

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Pancreatic Cancer Clinical Trials

Clinical Trial: BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology ...

Clinical trial focusing on BrUOG 278. BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study

Clinical Trial: Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer

Clinical trial focusing on mirtazapine and gemcitabine. Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer

Clinical Trial: Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX ...

Clinical trial focusing on sterotactic radion therapy and Folfirinox. Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer